Evaluation of glycemic status and subclinical atherosclerosis in familial hypercholesterolemia subjects with or without LDL receptor mutation

被引:0
作者
Barbagallo, Francesco Di Giacomo [1 ,3 ]
Bosco, Giosiana [1 ,3 ]
Di Marco, Maurizio [1 ]
Scilletta, Sabrina [1 ]
Miano, Nicoletta [1 ]
Musmeci, Marco [1 ]
Martedi, Marina [1 ]
Gonzalez-Lleo, Ana M. [2 ]
Ibarretxe, Daiana [2 ]
De Francesco, Ernestina Marianna [3 ]
Malaguarnera, Roberta [3 ]
Di Pino, Antonino [1 ]
Masana, Luis [2 ]
Purrello, Francesco [1 ]
Piro, Salvatore [1 ]
Scicali, Roberto [1 ]
机构
[1] Univ Catania, Garibaldi Hosp, Dept Clin & Expt Med, Internal Med, Via Palermo 636, I-95122 Catania, Italy
[2] Univ Rovira i Virgili, Hosp Univ St Joan, Unitat Med Vasc & Metab, Unitat Recerca Lipids & Arterioslcerosi, Reus, Spain
[3] Kore Univ Enna, Dept Med & Surg, Enna, Italy
关键词
Familial hypercholesterolemia; Low-density lipoprotein receptor; Glycemic status; Subclinical atherosclerosis; Cardiovascular risk; LOW-DENSITY-LIPOPROTEIN; RISK; BURDEN; SCORE; ASSOCIATION; VARIANTS; DISEASE; PROFILE;
D O I
10.1186/s12933-025-02683-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Familial hypercholesterolemia (FH) is a genetic condition characterized by elevated LDL-C and increased cardiovascular risk. Beyond LDL-C levels, the impact of genotype on glucose homeostasis has not been well evaluated. We aimed to evaluate the impact of genotype on glycemic status and on atherosclerotic injury in FH subjects. Methods We conducted a cross-sectional study on 322 FH subjects not on lipid-lowering therapy and without history of cardiovascular disease. Biochemical and genetic analyses as well as vascular profile assessment were obtained from all subjects. The study population was divided into two groups according to genotype: LDL receptor (LDLR) group and non-LDLR (NLDLR) group. Results The LDLR group exhibited a higher prevalence of low glycemic status (LGS) than the NLDLR group (44.1% vs. 26%, p < 0.01), whereas a high glycemic status (HGS) was more prevalent in the NLDLR group compared with LDLR group (74% vs. 55.9%, p < 0.01). The NLDLR group exhibited a higher prevalence of peripheral atherosclerotic plaques than the LDLR group (93.4% vs. 73%, p < 0.05), while coronary artery calcification (CAC) presence was more prevalent in the LDLR group compared with the NLDLR group (74.7% vs. 48%, p < 0.01). In a secondary analysis the study population was stratified into three groups based on LDLR genotype: NLDLR, LDLR defective, LDLR null groups. The prevalence of LGS progressively increased from the NLDLR to the LDLR null group, while HGS showed an inverse trend (p for trend < 0.05). Peripheral atherosclerotic plaque prevalence decreased from the NLDLR to the LDLR null group (p for trend < 0.05), while CAC prevalence increased progressively in the three groups (p for trend < 0.01). Logistic regression analysis showed that FH groups with an LDLR mutation were inversely associated with HGS (p for both < 0.01) and the LDLR null group exhibited the strongest association. Conclusions FH subjects with NLDLR mutations exhibited a worse glycemic profile, while null LDLR mutations showed the strongest inverse association with HGS. The integrations of genetic, lipid and glucose data could be useful to better identify the metabolic profile and the atherosclerosis distribution in FH subjects.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Comprehensive Prediction of Subclinical Coronary Atherosclerosis in Subjects Without Traditional Cardiovascular Risk Factors
    Park, Sangwoo
    Jeon, Young-Jee
    Ann, Soe Hee
    Kim, Yong-Giun
    Lee, Yongjik
    Choi, Seong Hoon
    Han, Seungbong
    Park, Gyung-Min
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2023, 198 : 64 - 71
  • [32] IDENTIFICATION OF THE VALINE-408 TO METHIONINE MUTATION IN THE LDL RECEPTOR IN A GREEK PATIENT WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    SCHUSTER, H
    MANKE, C
    FISCHER, J
    KELLER, C
    WOLFRAM, G
    ZOLLNER, N
    [J]. CLINICAL GENETICS, 1995, 48 (02) : 90 - 92
  • [33] FH AFRIKANER-3 LDL RECEPTOR MUTATION RESULTS IN DEFECTIVE LDL RECEPTORS AND CAUSES A MILD FORM OF FAMILIAL HYPERCHOLESTEROLEMIA
    VANROGGEN, JFG
    VANDERWESTHUYZEN, DR
    COETZEE, GA
    MARAIS, AD
    STEYN, K
    LANGENHOVEN, E
    KOTZE, MJ
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (06) : 765 - 772
  • [34] Lipoprotein(a) Levels in Familial Hypercholesterolemia An Important Predictor of Cardiovascular Disease Independent of the Type of LDL Receptor Mutation
    Alonso, Rodrigo
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (19) : 1983 - 1989
  • [35] Maternal Inheritance of Familial Hypercholesterolemia Gene Mutation Predisposes to Coronary Atherosclerosis as Assessed by Calcium Score in Adulthood
    Mourre, Florian
    Giorgi, Roch
    Gallo, Antonio
    Boccara, Franck
    Bruckert, Eric
    Carrie, Alain
    Hankard, Regis
    Inamo, Jocelyn
    Laboureau, Sandrine
    Moulin, Philippe
    Valero, Rene
    Beliard, Sophie
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43 (02) : E94 - E103
  • [36] Spectrum of LDL receptor gene mutations in heterozygous familial hypercholesterolemia
    Day, INM
    Whittall, RA
    ODell, SD
    Haddad, L
    Bolla, MK
    Gudnason, V
    Humphries, SE
    [J]. HUMAN MUTATION, 1997, 10 (02) : 116 - 127
  • [37] Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia
    Scicali, Roberto
    Di Pino, Antonino
    Urbano, Francesca
    Ferrara, Viviana
    Marchisello, Simona
    Di Mauro, Stefania
    Scamporrino, Alessandra
    Filippello, Agnese
    Piro, Salvatore
    Rabuazzo, Agata Maria
    Purrello, Francesco
    [J]. ACTA DIABETOLOGICA, 2019, 56 (08) : 899 - 906
  • [38] Identification of a novel mutation in exon 13 of the LDL receptor gene causing familial hypercholesterolemia in two spanish families
    Cenarro, A
    Jensen, HK
    Casao, E
    Civeira, F
    GonzalezBonillo, J
    Pocovi, M
    Gregersen, N
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1996, 1316 (01): : 1 - 4
  • [39] A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene
    Wang, DQ
    Wu, BQ
    Li, Y
    Heng, WJ
    Zhong, HH
    Mu, Y
    Wang, JJ
    [J]. JOURNAL OF HUMAN GENETICS, 2001, 46 (03) : 152 - 154
  • [40] A de novo mutation of the LDL receptor gene as the cause of familial hypercholesterolemia identified using whole exome sequencing
    Tada, Hayato
    Hosomichi, Kazuyoshi
    Okada, Hirofumi
    Kawashiri, Masa-aki
    Nohara, Atsushi
    Inazu, Akihiro
    Tomizawa, Shigeru
    Tajima, Atsushi
    Mabuchi, Hiroshi
    Hayashi, Kenshi
    [J]. CLINICA CHIMICA ACTA, 2016, 453 : 194 - 196